Merck has unveiled a new pill that slashes "bad" LDL cholesterol—by at least half in two-thirds of patients, per STAT ...

"These findings suggest that while PCSK9 inhibitors are safe and effective at lowering lipids, their impact on early vascular remodeling in heart transplant recipients may be limited -- at least ...

The drug enlicitide reduced cholesterol for adults with high levels due to an inherited disorder and may also work for a broader population.

The pill is called enlicitide, and in early studies, it has shown the power to lower levels of “bad” LDL cholesterol by up to ...

What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?

A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes ...

A new Merck pill called enlicitide slashes levels of harmful LDL cholesterol by up to 60%, similar to injectable PCSK9 drugs ...

Key Takeaways Merck’s new pill, enlicitide, lowered LDL cholesterol by up to 60% in a new trialThe pill works just as well as ...

The researchers found that people with lower LDL levels had fewer major cardiovascular problems and fewer strokes. For ...

Shares rise 8.5% on enlicitide decanoate Phase 3 data showing LDL reduction. Q3 earnings beat at $2.58/share with $17.3B ...

Researchers sought to examine socioeconomic and racial disparities related to use of PCSK9 inhibitors in patients with ASCVD.

LDL cholesterol level < 40 vs ≥ 70 mg/dL is linked to lower rates of future major cardiovascular events in patients with ...